Business Context and Reporting Period
Company: TherapeuticsMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 9, 2018
Reporting Period: Single event date (January 9, 2018)
This filing serves as a Regulation FD disclosure to furnish an investor presentation (Exhibit 99.1) intended for use in meetings with investors and analysts on and after January 9, 2018.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to disclose the existence of an investor presentation rather than a financial statement.
Material Changes
No material changes to financial performance or operations are reported within the text of this filing. The primary event is the distribution of forward-looking information contained in the attached investor presentation.
Guidance, Outlook, and Risks
- Management Commentary: The company is furnishing an investor presentation dated January 2018. The text notes this information may be subject to modification.
- Legal Status of Information: The information in this report and its exhibits is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section.
- Incorporation by Reference: The information will not be incorporated by reference into any other filings under the Securities Act or Exchange Act unless expressly set forth by specific reference.
Investor Verification Checklist
- Review Exhibit 99.1 (TherapeuticsMD, Inc. presentation dated January 2018) for specific financial projections and strategic updates, as the 8-K text itself contains no numerical data.
- Verify that any forward-looking statements in the presentation are understood as subject to modification and not legally "filed" for liability purposes under Section 18.
- Confirm the date of the presentation matches the filing date (January 2018) to ensure the data is current relative to the report.